// explore
Search any US ticker to see real SEC Form 4 insider transactions. Free, no account needed — this page is powered by the live Form4API insider trading API.
38 filings on record
Transactions (30d)
—
Last Filing
Nov 8, 2023
30-Day Sentiment
Neutral| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 8, 2023 | Thorell Marella See Remarks | Sale10b5 | 1,811 | $0.33 | $1K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
// about this data
Every result on this page comes from SEC Form 4 filings — the disclosures that company directors, officers, and shareholders owning more than 10% must file within two business days of buying or selling their company's stock. Enter any US ticker to see that company's most recent insider transactions: who traded, whether it was an open-market purchase or sale, the number of shares, and the price.
Open-market purchases (transaction code P) are the most closely watched signal, because an insider spending their own money to buy shares is a discretionary vote of confidence. Sales (code S) are noisier — insiders sell for many reasons unrelated to their view of the company, from diversification to tax planning. Trades made under a pre-scheduled Rule 10b5-1 plan carry no timing signal at all.
The same data is available programmatically through the Form4API insider trading API — real-time webhooks, amendment-aware parsing, and full history. New to Form 4? Start with our guide to reading SEC Form 4 filings.
| Nov 8, 2023 | GILL SIMBA President & CEO | Sale10b5 | 172 | $0.33 | $0K |
| Nov 8, 2023 | Bodmer Mark CSO, President of R&D | Sale10b5 | 3,163 | $0.33 | $1K |
| Nov 8, 2023 | McHale Duncan Chief Medical Officer | Sale10b5 | 3,103 | $0.33 | $1K |
| Nov 7, 2023 | McHale Duncan Chief Medical Officer | Option Exercise | 6,500 | $0.00 | $0K |